NR3C1 and psoriasis: CXXC1 is known to be recruited by the glucocorticoid receptor as part of a complex to methylate H3K496, and the glucocorticoid receptor is the most frequent treatment target for psoriasis and atopic dermatitis97,98, supporting further study of the interplay between epidermis-intrinsic CXXC1 activity and surrounding inflammatory cells.